Archives
Press Releases
advertisement
June 24, 2020
- Provention Bio’s Teplizumab Continued to Significantly Delay the Onset of Insulin-Dependent Type 1 Diabetes (T1D) in Presymptomatic Patients
- Tandem Diabetes Care Acquires Sugarmate, a Popular Mobile App for People with Diabetes
- Lilly launches program about what people with diabetes should “Know Before the Low™”
June 17, 2020
- Tandem Diabetes Care Announces Expanded Pediatric Indication of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
- Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)
- One in Three People with Diabetes Do Not Receive Support Needed to Deal with Emotional Aspects of Living with Diabetes
- Medtronic Presents U.S. Pivotal Trial Data for MiniMed™ 780G Advanced Hybrid Closed Loop System with Automated Correction Bolus Feature
- FDA approves Lyumjev™ (insulin lispro-aabc injection), Lilly’s new rapid-acting insulin
- Latest TEDDY Report Outlines Research on Type 1 Diabetes and Celiac Disease
June 3, 2020
- Bigfoot Biomedical® Closes Series C Financing with $55 Million as Company Readies for FDA Submission of Bigfoot Unity
- FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products
- A New Book for Anyone With Type 1 Diabetes — “Actually, I Can.” by 19-year-old Author — Gives Insight and Inspiration
advertisement
